Name | Number of supported studies | Average coverage | |
---|---|---|---|
enteroendocrine cell | 6 studies | 63% ± 26% | |
pancreatic A cell | 4 studies | 77% ± 11% | |
type B pancreatic cell | 4 studies | 83% ± 8% | |
neuroendocrine cell | 4 studies | 66% ± 8% | |
pancreatic D cell | 3 studies | 81% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreas | 4 studies | 55% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1995.95 | 328 / 328 | 75% | 107.52 | 133 / 178 |
intestine | 98% | 834.73 | 947 / 966 | 13% | 5.39 | 67 / 527 |
prostate | 28% | 57.18 | 69 / 245 | 74% | 21.60 | 370 / 502 |
kidney | 26% | 53.24 | 23 / 89 | 72% | 73.97 | 649 / 901 |
stomach | 82% | 202.85 | 295 / 359 | 12% | 6.60 | 33 / 286 |
liver | 26% | 40.77 | 58 / 226 | 58% | 32.06 | 234 / 406 |
heart | 64% | 357.11 | 555 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 36% | 81.45 | 94 / 258 | 28% | 16.23 | 64 / 230 |
adipose | 53% | 204.09 | 636 / 1204 | 0% | 0 | 0 / 0 |
brain | 38% | 696.07 | 992 / 2642 | 13% | 3.25 | 94 / 705 |
breast | 35% | 132.49 | 161 / 459 | 13% | 7.53 | 149 / 1118 |
thymus | 29% | 84.16 | 189 / 653 | 5% | 0.37 | 28 / 605 |
esophagus | 22% | 44.92 | 318 / 1445 | 5% | 3.20 | 9 / 183 |
blood vessel | 12% | 25.90 | 163 / 1335 | 0% | 0 | 0 / 0 |
ovary | 4% | 7.12 | 8 / 180 | 1% | 0.12 | 3 / 430 |
lung | 1% | 2.15 | 4 / 578 | 4% | 1.61 | 45 / 1155 |
bladder | 0% | 0 | 0 / 21 | 4% | 3.73 | 18 / 504 |
uterus | 0% | 0 | 0 / 170 | 2% | 0.21 | 11 / 459 |
tonsil | 0% | 0 | 0 / 0 | 2% | 16.51 | 1 / 45 |
skin | 0% | 1.21 | 7 / 1809 | 1% | 0.07 | 5 / 472 |
eye | 0% | 0 | 0 / 0 | 1% | 0.08 | 1 / 80 |
muscle | 0% | 0.49 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1900271 | Biological process | regulation of long-term synaptic potentiation |
GO_0008150 | Biological process | biological_process |
GO_0099509 | Biological process | regulation of presynaptic cytosolic calcium ion concentration |
GO_0043195 | Cellular component | terminal bouton |
GO_0030658 | Cellular component | transport vesicle membrane |
GO_0005829 | Cellular component | cytosol |
GO_0030425 | Cellular component | dendrite |
GO_0005576 | Cellular component | extracellular region |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SCGN |
Protein name | Secretagogin Secretagogin, EF-hand calcium binding protein (Setagin) |
Synonyms | hCG_19125 SECRET |
Description | |
Accessions | O76038 Q96P10 ENST00000377961.3 ENST00000612225.4 |